21.6: Chapter 7
- Page ID
- 122134
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\( \newcommand{\dsum}{\displaystyle\sum\limits} \)
\( \newcommand{\dint}{\displaystyle\int\limits} \)
\( \newcommand{\dlim}{\displaystyle\lim\limits} \)
\( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)
( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\id}{\mathrm{id}}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\kernel}{\mathrm{null}\,}\)
\( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\)
\( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\)
\( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)
\( \newcommand{\vectorA}[1]{\vec{#1}} % arrow\)
\( \newcommand{\vectorAt}[1]{\vec{\text{#1}}} % arrow\)
\( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vectorC}[1]{\textbf{#1}} \)
\( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)
\( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)
\( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\(\newcommand{\longvect}{\overrightarrow}\)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\(\newcommand{\ket}[1]{\left| #1 \right>}\)
\(\newcommand{\bra}[1]{\left< #1 \right|}\)
\(\newcommand{\braket}[2]{\left< #1 \vphantom{#2} \right| \left. #2 \vphantom{#1} \right>}\)
\(\newcommand{\braopket}[3]{\left< #1 \vphantom{#2}\vphantom{#3} \right| #2 \vphantom{#1}\vphantom{#3} \left| #3 \vphantom{#1}\vphantom{#2} \right>}\)
\(\newcommand{\qmvec}[1]{\mathbf{\vec{#1}}}\)
\(\newcommand{\op}[1]{\hat{\mathbf{#1}}}\)
\(\newcommand{\expect}[1]{\langle #1 \rangle}\)
\(\newcommand{\dfn}[1]{\emph{\textbf{#1}}}\)
Autism Case Study
Answers
- A – Risk for self-injury related to head banging and scratching. Self-injurious behaviors are an immediate safety concern and should be prioritized.
- D – Asking Diego’s mother to interpret his nonverbal cues and provide a pain rating. Diego’s mother is the most familiar with his nonverbal cues and can accurately assess his pain.
- B – Diego will demonstrate one alternative coping mechanism when feeling agitated. This is a realistic, measurable goal that aligns with Diego’s developmental stage and abilities.
- B – Diego’s agitation decreased from highly agitated to mildly agitated following the implementation of sensory strategies, including dimming lights and providing noise-canceling headphones. The documentation is specific and reflects measurable changes in Diego’s behavior.
- B – Sensory sensitivities related to food textures can be common in children and may be linked to developmental or sensory processing issues. Forcing a child to eat certain foods or implementing overly strict routines can increase mealtime stress and worsen eating behaviors. A registered dietician can assess Diego’s specific needs and preferences and help develop a plan that meets his nutritional requirements while respecting his sensory challenges.
- C – Place soft padding around Diego to minimize injury and allow him to calm down independently. Ensuring safety while allowing self-regulation helps manage frustration without escalating agitation.
Mental Health Medication Match Up
Answer Key
| Medication Class and Examples | Anxiety | Depression | Bipolar | Schizophrenia | SUD | Eating Disorder | ADHD |
|---|---|---|---|---|---|---|---|
| SSRI
(Fluoxetine, sertraline and citalopram) |
X | X | X – Bulimia | ||||
| SNRI
(Venlafaxine, duloxetine, atomoxetine) |
X | X | X | ||||
| Mood Stabilizer
(Lithium) |
X | ||||||
| Benzodiazepines
(Clonazepam, alprazolam, lorazepam) |
X | Withdrawal | |||||
| Anti-convulsant
(Gabapentin, valproic acid) |
X | X | |||||
| Anxiolytic
(buspirone) |
X | ||||||
| First-Generation Antipsychotic
(haloperidol, chlorpromazine) |
X | ||||||
| NDRI
(bupropion) |
X | ||||||
| Beta-blocker
(Propranolol) |
X | ||||||
| Stimulants
(Methylphenidate) |
X | ||||||
| Second- Generation Antipsychotic
(Risperidone) |
X | X | |||||
| MAOI
(Isocarboxazid) |
X | X |
Please find answers to the Learning Activity interactive elements within the element.

